Anicemycin, a new inhibitor of anchorage-independent growth of tumor cells from Streptomyces sp. TP-A0648

J Antibiot (Tokyo). 2005 May;58(5):322-6. doi: 10.1038/ja.2005.40.

Abstract

The anchorage-independence of cells is closely related to their tumorigenicity. In the screening of inhibitors of anchorage-independent growth of tumor cells, anicemycin was isolated from the fermentation broth of an actinomycete strain TP-A0648. The producing strain was isolated from a leaf of Aucuba japonica collected in Toyama, Japan and identified as Streptomyces sp. based on the taxonomic data. The structure of anicemycin was elucidated as a new analog of spicamycin by NMR and MS analysis. Anicemycin inhibited the anchorage-independent growth of the human ovary cancer SKOV-3 cells with an IC50 of 0.015 microM about three times more potently than their anchorage-dependent growth.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibiotics, Antineoplastic / biosynthesis
  • Antibiotics, Antineoplastic / chemistry
  • Antibiotics, Antineoplastic / pharmacology*
  • Cell Proliferation / drug effects
  • Chemical Phenomena
  • Chemistry, Physical
  • Drug Screening Assays, Antitumor
  • Fermentation
  • Humans
  • Magnetic Resonance Spectroscopy
  • Mass Spectrometry
  • Microscopy, Electron, Scanning
  • Models, Molecular
  • Plant Leaves / microbiology
  • Purine Nucleosides / biosynthesis
  • Purine Nucleosides / chemistry
  • Purine Nucleosides / pharmacology*
  • Spectrophotometry, Ultraviolet
  • Streptomyces / classification
  • Streptomyces / metabolism*
  • Streptomyces / ultrastructure
  • Structure-Activity Relationship
  • Tumor Cells, Cultured

Substances

  • Antibiotics, Antineoplastic
  • Purine Nucleosides
  • anicemycin